Sharing Clinical Trial Data: Challenges and a Way Forward – A Workshop : Health and Medicine Division

“An ad hoc planning committee under the auspices of the National Academies of Sciences, Engineering, and Medicine, will plan and conduct a two-day public workshop to discuss advances, challenges, and opportunities in clinical trial data sharing efforts since the release of the 2015 Institute of Medicine report, Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk. This workshop is co-sponsored by the Wellcome Trust.

WORKSHOP OBJECTIVES:

Consider the value and potential risks/costs of sharing clinical trial data for key stakeholders, including clinical trialists, sponsors, primary and secondary researchers, and patients;
Review the current landscape of clinical trial data sharing and reuse across public and private sectors (e.g. policies, platforms, collaborations, data sharing culture, published research output);
Examine use cases and trends from across public and private sectors when it comes to success, failure, lessons learned, and value;
Consider the perspectives and expectations of primary and secondary researchers, clinical trial participants, patient organizations, research sponsors (pharmaceutical companies and nonprofit organizations), journals, institutions, and federal agencies; and
Discuss next step opportunities for stakeholders to better harmonize incentives, policy, data standards, and governance to encourage the sharing and reuse of clinical trial data.

The planning committee will organize the workshop, develop the agenda, select and invite speakers and discussants, and moderate or identify moderators for the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines….”

Roundtable on Aligning Incentives for Open Science

“In order to increase the contribution of open science to producing better science, the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Aligning Incentives for Open Science convenes critical stakeholders to discuss the effectiveness of current incentives for adopting open science practices, current barriers of all types, and ways to move forward in order to align reward structures and institutional values. The Roundtable convenes two times per year and creates a venue for the exchange of ideas and joint strategic planning among key stakeholders. Each Roundtable meeting has a theme. The diverse themes target slightly different audiences but the core audience will consist of universities, government agencies, foundations, and other groups doing work related to open science. The Roundtable aims to improve coordination among stakeholders and increase awareness of current and future efforts in the broader open science community. The Roundtable will also convene one symposium per year, which may produce National Academies proceedings in brief….”

Enhancing Scientific Reproducibility through Transparent Reporting – A Workshop : Health and Medicine Division

“An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is convening a public workshop to discuss the current state of transparency in reporting pre-clinical biomedical research (e.g., disclosure of the availability and location of data, materials, analysis, and methodology) and to explore the possibility of improving the harmonization of guidelines across journals and funding agencies so that biomedical researchers propose and report data in a consistent manner. This workshop is sponsored by the National Institutes of Health, Cell Press, The Lancet, and Nature Research.

WORKSHOP OBJECTIVES:

Highlight current efforts by researchers, institutions, funders, and journals to increase transparency in proposing and reporting pre-clinical biomedical research;
Discuss journal and funder assessments of researchers’ adherence to reporting guidelines, including a discussion of the effectiveness of checklists;
Consider lessons learned from field-specific best practices for increased transparency in reporting rigor elements (i.e., research design, methodology, analysis, interpretation and reporting of results) that are generalizable across biomedical research domains;
Discuss opportunities for improving the consistency of reporting guidelines and requirements for rigor and transparency by journals, funders, and institutions across the biomedical research lifecycle; and
Consider approaches to compare reporting of rigor elements proposed in grant applications to those included in publications.

The committee will plan and organize the workshop, develop the agenda, select and invite speakers and discussants, and moderate or identify moderators for the discussions. The agenda will include a panel discussion on facilitating the development of consistent guidelines (e.g. a common set of minimal reporting standards) that could be applied across journals and funders to increase transparency in proposing and reporting biomedical research.

A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines….”

July 6, 2015: Marcia K. McNutt Nominated to be Next NAS President

“The Council of the National Academy of Sciences has approved the nomination of Marcia K. McNutt, editor-in-chief of the Science family of journals, for election as president of the Academy, to succeed Ralph J. Cicerone when his second term as NAS president ends on July 1, 2016….As editor-in-chief she led the effort to establish Science Advances, an open access, online-only offspring of Science….”